Literature DB >> 24172318

IL-17 antibodies gain momentum.

Man Tsuey Tse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24172318     DOI： 10.1038/nrd4152

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Targeting IL-17 and TH17 cells in chronic inflammation.

Authors:  Pierre Miossec; Jay K Kolls
Journal:  Nat Rev Drug Discov       Date:  2012-10       Impact factor: 84.694
  1 in total
  7 in total

Review 1.  The Relapse of Psoriasis: Mechanisms and Mysteries.

Authors:  Danning Tian; Yuping Lai
Journal:  JID Innov       Date:  2022-03-09

Review 2.  Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

Authors:  Yuping Lai; Chen Dong
Journal:  Int Immunol       Date:  2015-11-06       Impact factor: 4.823

Review 3.  Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases.

Authors:  Haiyan Zhang; Francesca Bernuzzi; Ana Lleo; Xiong Ma; Pietro Invernizzi
Journal:  Mediators Inflamm       Date:  2015-06-04       Impact factor: 4.711

Review 4.  T cells in vascular inflammatory diseases.

Authors:  Lucas L Lintermans; Coen A Stegeman; Peter Heeringa; Wayel H Abdulahad
Journal:  Front Immunol       Date:  2014-10-14       Impact factor: 7.561

Review 5.  New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors.

Authors:  Anthony A Gaspari; Stephen Tyring
Journal:  Dermatol Ther       Date:  2015 Jul-Aug       Impact factor: 2.851

6.  Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.

Authors:  F Amicarella; M G Muraro; C Hirt; E Cremonesi; E Padovan; V Mele; V Governa; J Han; X Huber; R A Droeser; M Zuber; M Adamina; M Bolli; R Rosso; A Lugli; I Zlobec; L Terracciano; L Tornillo; P Zajac; S Eppenberger-Castori; F Trapani; D Oertli; G Iezzi
Journal:  Gut       Date:  2015-12-30       Impact factor: 23.059

7.  TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.

Authors:  Nima Etemadi; Michael Chopin; Holly Anderton; Maria C Tanzer; James A Rickard; Waruni Abeysekera; Cathrine Hall; Sukhdeep K Spall; Bing Wang; Yuquan Xiong; Timothy Hla; Stuart M Pitson; Claudine S Bonder; Wendy Wei-Lynn Wong; Matthias Ernst; Gordon K Smyth; David L Vaux; Stephen L Nutt; Ueli Nachbur; John Silke
Journal:  Elife       Date:  2015-12-23       Impact factor: 8.140
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.